D. E. Shaw & Co., Inc. Merck & Co., Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $33.7 Million - $39.1 Million	303,300 Added 93.76%	626,800 $71.2 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $21.8 Million - $23.4 Million	-176,100 Reduced 35.25%	323,500 $40 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $63.6 Million - $74.1 Million	-561,200 Reduced 52.9%	499,600 $65.9 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $22.1 Million - $24 Million	220,300 Added 26.21%	1,060,800 $116 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $11.1 Million - $12.3 Million	107,700 Added 14.7%	840,500 $86.5 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $4.53 Million - $4.94 Million	-41,700 Reduced 5.38%	732,800 $84.6 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $18.9 Million - $21.1 Million	183,300 Added 31.0%	774,500 $82.4 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $17.7 Million - $22.7 Million	202,400 Added 52.06%	591,200 $65.6 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6.75 Million - $7.59 Million	79,900 Added 25.87%	388,800 $33.5 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $11.3 Million - $12.8 Million	-135,300 Reduced 30.46%	308,900 $28.2 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $1.54 Million - $1.73 Million	21,000 Added 4.96%	444,200 $36.4 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $7.63 Million - $9.56 Million	105,600 Added 33.25%	423,200 $32.4 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $3.39 Million - $3.73 Million	47,300 Added 17.5%	317,600 $23.9 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $5.81 Million - $6.43 Million	82,700 Added 44.08%	270,300 $21 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1.56 Million - $1.84 Million	-22,700 Reduced 10.79%	187,600 $14.5 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $2.99 Million - $3.32 Million	41,700 Added 24.73%	210,300 $17.2 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $1.78 Million - $2.02 Million	-24,300 Reduced 12.6%	168,600 $14 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $7.75 Million - $8.82 Million	-110,100 Reduced 36.34%	192,900 $14.9 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $13.5 Million - $18.7 Million	-212,600 Reduced 41.23%	303,000 $23.3 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $985,266 - $1.11 Million	12,700 Added 2.53%	515,600 $46.9 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $10.1 Million - $11 Million	-132,500 Reduced 20.85%	502,900 $42.3 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $25.5 Million - $29.8 Million	-364,900 Reduced 36.48%	635,400 $53.3 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $13.3 Million - $15.2 Million	-191,000 Reduced 16.03%	1,000,300 $83.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $48.3 Million - $56 Million	739,600 Added 163.74%	1,191,300 $91 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $3.4 Million - $4 Million	58,900 Added 14.99%	451,700 $32 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $376,142 - $441,928	-7,400 Reduced 1.85%	392,800 $23.8 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $7.02 Million - $8.16 Million	137,700 Added 52.46%	400,200 $21.8 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $13.6 Million - $16.2 Million	262,500	262,500 $14.8 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.5 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.3 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.7 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.43 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.8 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account